Diamyd Medical AB's Phase III Study Published in The New England Journal of Medicine
2/2/2012 6:41:30 AM
STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
An article with the results of Diamyd Medical's European Phase III study of the antigen-based diabetes therapy Diamyd® has been published in the scientific journal the New England Journal of Medicine. The now published results were previously presented at the American Diabetes Association’s 71st Scientific Sessions in San Diego, California, USA, on June 28, 2011.